Abstract
: To investigate the effect of Eupalinolide B (EB) on amyotrophic lateral sclerosis (ALS). Method: EB was administered 20 mg/d orally
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.52338/wjoncgy.2023.1019
Journal: World Journal of Medical Oncology | Publication Date: Jan 10, 2024 |
: To investigate the effect of Eupalinolide B (EB) on amyotrophic lateral sclerosis (ALS). Method: EB was administered 20 mg/d orally
Join us for a 30 min session where you can share your feedback and ask us any queries you have